Mirae Asset Global ETFs Holdings’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$168K Buy
88,487
+3,241
+4% +$5.56K ﹤0.01% 2442
2025
Q4
$136K Buy
+85,246
New +$179K ﹤0.01% 2537
2025
Q2
Sell
-168,610
Closed -$154K 3052
2025
Q1
$154K Sell
168,610
-8,044
-5% -$10.5K ﹤0.01% 2446
2024
Q4
$281K Buy
176,654
+8,199
+5% +$16.5K ﹤0.01% 2215
2024
Q3
$330K Sell
168,455
-23,107
-12% -$47.3K ﹤0.01% 2118
2024
Q2
$314K Buy
+191,562
New +$612K ﹤0.01% 2046

Other funds holding CRBU

Mirae Asset Global ETFs Holdings's CRBU Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Caribou Biosciences (CRBU) stake by 3.8% in Q1 2026, buying an estimated $5.56K and bringing the position to 88,487 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #2442.

Mirae Asset Global ETFs Holdings first reported a position in CRBU in Q2 2024 and has held it in 6 quarters since. The position peaked at $330K in Q3 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 88,487 shares of Caribou Biosciences worth $168K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 3,241 Caribou Biosciences shares in Q1 2026, an estimated $5.56K.
  • Caribou Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2442 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Caribou Biosciences in Q2 2024 and has held it in 6 quarters since.
  • Mirae Asset Global ETFs Holdings's Caribou Biosciences position peaked at $330K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.